LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 658 320 2.0540 1.4525
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 859 320 2.6814 1.6450
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 794 320 2.4785 1.5867
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
5.36 27.76 761 320 2.3755 1.5557
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 13 360 0.0361 -0.1855
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 739 360 2.0528 1.4295
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 2 360 0.0056 -0.5091
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 929 360 2.5806 1.5846
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 896 360 2.4889 1.5594
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
7.06 27.76 893 360 2.4806 1.5571
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 15 401 0.0374 -0.1476
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 811 401 2.0217 1.4009
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 4 401 0.0100 -0.3952
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 1025 401 2.5552 1.5513
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 1005 401 2.5053 1.5383
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
8.76 27.76 985 401 2.4555 1.5251
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
10.46 27.76 17 438 0.0388 -0.1159
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
10.46 27.76 863 438 1.9674 1.3705
MN20160318_Q01
G22